ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation

Technological advancements in donor organ transportation answer the growing demand for comprehensive tracking, monitoring, and data reporting

Paragonix Technologies, Inc., a leader in Advanced Organ Preservation (AOP) technology, has announced the launch of its new VantagePoint™ Organ Tracking Technology to pioneer a new era of continuous oversight and real-time visibility for donor organs in transit. Designed to meet the rising standards of transparency and accountability in donor organ transportation, this technology will improve the digital tracking capabilities provided by the Paragonix App, the free-to-download software, paired with all Paragonix Advanced Organ Preservation (AOP) Devices to meet the evolving needs of organ transplant professionals.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221018005317/en/

Since 2019, the Paragonix App has allowed teams to easily coordinate the logistics of safeguarding a donor organ in transit. In addition to managing HIPAA-compliant team communications, the app actively monitors preservation conditions in real-time and tracks the GPS location of the procurement team en route to the recipient hospital.

“Protecting the gift of life takes a team of skilled professionals to be successful. With teams from different hospitals working together, sometimes on a national level, it is crucial that all involved members can carefully monitor and track the exact location and condition of the valuable organ throughout every step of the process,” said Dr. Lisa Anderson, CEO of Paragonix. “We have always emphasized the importance of delivering transplant professionals the greatest levels of data and visibility, which is why we are proud to continue expanding our custom digital offering with unparalleled levels of tracking insights.”

With the launch of VantagePoint™ Advanced Organ Tracking, Paragonix device users can begin utilizing state-of-the-art GPS technology to capture and transmit accurate location data of the device autonomously, regardless of cellular or Wi-Fi connectivity. The industry’s current standard of care in preservation - carefully placing a donor organ in ice storage - lacks the level of control or data coordination that transplant professionals deserve to access in an era of digital innovation.

The latest Paragonix App update also optimizes the common limitations of air travel, allowing users to directly upload flight information through a new integration of FlightAware® software. This functionality automatically delivers flight tracking data and predictive insights that can determine the plane’s estimated time of arrival, allowing teams to visualize the complete journey to the recipient hospital and act accordingly.

For more information about either the Paragonix Web Portal or the mobile app, visit paragonixtechnologies.com.

About Paragonix Technologies

Paragonix Technologies creates organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix is a leading provider of FDA cleared and CE marked transport devices for organ preservation.

Follow us on Twitter: @ParagonixSherpa

Connect with us on LinkedIn: Paragonix Technologies

Like Us on Facebook: Paragonix SherpaPak

L-399 Rev 1

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.